The Four-Risk Framework for Evaluating Medtech Opportunities: Interview with SonoVascular CEO Daniel Estay
From Medsider: Learn from Medtech and Healthtech Founders and CEOs by Scott Nelson
March 23, 2026 · 52 min
About this episode
Daniel Estay discusses evaluating medtech opportunities and the importance of relationships in the industry.
In this episode of Medsider Radio , we sat down with Daniel Estay , founder and CEO of SonoVascular . SonoVascular has developed a novel mechanical-pharmaco ultrasound facilitated thrombectomy system, SonoThrombectomy, that utilizes microbubble-mediated cavitation as a core enabling mechanism to remove blood clots more effectively. Dan has over 35 years of global medtech experience, including business development roles at Johnson & Johnson, where he worked on deals that helped create the world's first drug-eluting stent, and six years leading Abbott's cardiovascular device business across Asia-Pacific and Japan. He also serves as a Mentor-in-Residence at Duke University's New Ventures group. In this interview, Dan discusses how to evaluate whether a medtech opportunity is commercially viable beyond technical feasibility, how trust and long-standing relationships matter more than geography when selecting first-in-human sites, and why cap table strategy requires deliberate thinking from the earliest stages — including when to transition from convertible notes to priced rounds. Before we dive into the discussion, I wanted to mention a few things: First, if you’re into learning…
People in this episode
Host: Scott Nelson
Guest: Daniel Estay
Topics covered
- medtech
- healthtech
- entrepreneurship
- business development
- thrombectomy
- investment strategy
Keywords
- medtech
- healthtech
- SonoVascular
- thrombectomy
- investment strategy
- business development
- Duke University
- Johnson & Johnson
- Abbott
Mentioned in this episode
Organizations: SonoVascular, Johnson & Johnson, Abbott, Duke University
Products: SonoThrombectomy
More episodes of Medsider: Learn from Medtech and Healthtech Founders and CEOs
- Building Clinical Evidence Around Your Target Market: Interview with Teal Health CEO Kara Egan · June 8, 2026 · 56 min
- Solving for Healthcare’s Broken Doorway: Interview with OnMed CEO Karthik Ganesh · June 1, 2026 · 51 min
- Meeting Patients Where They Are: Interview with Clairity CEO Dr. Connie Lehman · May 26, 2026 · 50 min
- Translating Academic IP into a Medtech Startup: Interview with Echopoint Medical CEO Antony Odell · May 18, 2026 · 52 min
- Why Early Revenue is the Most Credible Proof in Medtech: Interview with restor3d CEO Kurt Jacobus · May 12, 2026 · 55 min
- Finding the Clinical Need Hiding in Plain Sight: Interview with LightForce CEO Alfred Griffin · May 4, 2026 · 51 min
Explore listener stats, chart rankings, contacts and more on the Medsider: Learn from Medtech and Healthtech Founders and CEOs podcast page.